The Center focuses on applying stem cells in understanding developmental biology, cell therapy proof of concepts, and drug testing using organoids. The division also aims to develop marketable products involving stem cells. The vision is to learn about stem cells and developmental biology to devise novel strategies for preventing, diagnosing, and treating metabolic and geriatric diseases and cancer. Objectives include understanding basic developmental biology, designing in vitro differentiation protocols for cell therapy, creating organoid models for drug testing, and developing animal models for various stem cell therapies. The division aims to produce marketable products like in vitro cultured meat from muscle stem cells.. Over the next five years, the division is expected to grow and involve additional faculties with expertise across various stem cell biology disciplines. In summary, the Division of Regenerative and Cancer Stem Cells seeks to advance knowledge in stem cell biology, develop innovative applications in cell therapy and drug testing, and create marketable products using stem cells. With interdisciplinary collaboration and research funding, the division aims to contribute to regenerative medicine and cancer therapies breakthroughs.
- Pluripotent stem cell differentiation into endodermal lineages
- Cancer stem cells and Tumor models
- Stem cell cultures and clinical biopsies
- Muscle stem cell Biology
- Stem Cells and homeopathy formulations
- Stem cell-based therapies